Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPER: Corifollitropin Alfa vs Pergoveris in Suboptimal Responders
NCT03177538Phase 4Completed
- Sponsor
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Start
- Sep 2017
- Primary completion
- Nov 2018
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of corifollitropin alfa in female infertility (2 arms), sponsored by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. Primary endpoint: Number of cumulus-oocyte complexes. Started Sep 2017; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03177538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177538.